書誌事項
- タイトル別名
-
- Investigation Concerning Combined Use of Acidophilus Biologics and Antibiotics or Anticancer Drugs
この論文をさがす
抄録
Diarrhea is a very common,important adverse effect associated with antibiotic therapy.For the prevention and treatment of diarrhea,Biofermin (BF) probiotic preparations are prescribed frequently and an antibiotic-resistant probiotic BioferminR (BFR) is particularly useful against antibiotic-associated diarrhea.BFR is often prescribed in combination with antibiotics to which the probiotic is susceptible or with off-label drugs such as anti-cancer drugs.<br>We investigated the concurrent usage of such probiotics and antibiotics and anti-cancer drugs using data from the database of a computer order entry system at the Tokushima University Hospital (April 2006 to March 2008),as well through the use of a questionnaire given to hospital doctors.The results of our study suggested that not all doctors had a sufficient knowledge of the usage of BFR when prescribing it.In routine pharmacy work,pharmacists should therefore actively question doctors concerning prescriptions they have written for the combination of BFR and off-label drugs to ensure the proper use of BFR and prevent the emergence of drug-resistant bacteria due to bacterial mutagenicity associated with antibiotics and anti-cancer drugs.
収録刊行物
-
- 医療薬学
-
医療薬学 35 (5), 360-367, 2009
一般社団法人日本医療薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204777407104
-
- NII論文ID
- 10025973465
-
- NII書誌ID
- AA11527197
-
- ISSN
- 18821499
- 1346342X
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可